Abstract:
The purpose of the study was a comprehensive assessment of the pain syndrome major indices in patients with mandibular fractures accompanied by injury of the inferior alveolar nerve using conventional therapeutic regimen supplemented by the administration of drug product Nucleo CMP Forte. Decrease of pain syndrome was revealed in both groups but with different dynamic pattern. At the beginning of the study LANSS scale indices were nearly identical in both groups, while on the 7th and 14th day they were 1.35 and 2.03 times lower, respectively, in treatment group than in comparison group. On the first day NTSS-9 scale values did not practically differ in studied patients, being somewhat higher in treatment group. On the 7th and 14th day the values
were 1.24 and 3.82 times better, respectively, in treatment group than in the group of comparison. The analysis of dynamic pattern
of complaints as well as the objective findings in angular fractures of the mandible, accompanied by the damage of inferior alveolar
nerve, demonstrated that the administration of drug product Nucleo CMP Forte accelerated the regression of pain syndrome in the
course of treatment.
